FDA questions benefit of cystic fibrosis drug from Vertex (Update) - Vertex Pharmaceuticals - Document - PDFSEARCH.IO

First Page	Meta Content
	FDA questions benefit of cystic fibrosis drug from Vertex (Update) Add to Reading List Document Date: 2015-05-18 04:50:25 Open Document File Size: 16,71 KB Share Result on Facebook City Cambridge / / Company The Associated Press / Vertex Pharmaceuticals Inc. / / Country United States / / Currency USD / / Event FDA Phase / Person Communication and Meetings / Funding / Product Issues / M&A / / IndustryTerm online review / / MedicalCondition inherited disease / disease / cystic fibrosis / infections / / Organization FDA / Cystic Fibrosis Foundation / Food and Drug Administration / / Position elementary school / / Product Kalydeco / protein / Vertex's drug / / ProvinceOrState Massachusetts / / URL http / SocialTag Cystic fibrosis Pediatrics Vertex Pharmaceuticals Ivacaftor Cystic Fibrosis Foundation Food and Drug Administration Cystic Fibrosis Trust Health Medicine Channelopathy

FDA questions benefit of cystic fibrosis drug from Vertex (Update)Add to Reading List